L. Suurinkeroinen

Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus

L. Groop, M. Orho-Melander, M. Taskinen, 2000, Diabetic medicine : a journal of the British Diabetic Association.

Prevalence of hyperapobetalipoproteinemia and factors affecting the phenotype expression in children and young adults. The Cardiovascular Risk in Young Finns Study.

T. Lehtimäki, J. Viikari, O. Raitakari, 1996, Atherosclerosis.

No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.

L. Peltonen, M. Perola, J. Viikari, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Phenotype expression in familial combined hyperlipidemia.

T. Lehtimäki, L. Peltonen, M. Perola, 1997, Atherosclerosis.

Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant.

M. Taskinen, H. Yki-Järvinen, M. Syvänne, 1999, Journal of lipid research.

Serum complement and familial combined hyperlipidemia.

L. Peltonen, J. Viikari, M. Taskinen, 1997, Atherosclerosis.

Development and Evaluation of an ELISA Method for the Determination of Lipoprotein Lipase Mass Concentration — Comparison with a Commercial, One-Step Enzyme Immunoassay

M. Taskinen, M. Jauhiainen, C. Ehnholm, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group.

J. Viikari, M. Taskinen, P. Pajukanta, 1998, European journal of clinical investigation.